These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 650223)

  • 21. 6-Hydroxydopamine sensitivity in mouse neuroblastoma and neuroblastoma x L-cell hybrids.
    Cronemeyer RL; Thuillez PE; Shows TB; Morrow J
    Cancer Res; 1974 Jul; 34(7):1652-7. PubMed ID: 4858113
    [No Abstract]   [Full Text] [Related]  

  • 22. Replicon size increase due to 5-bromodeoxyuridine incorporation.
    Flickinger RA; Grabar F; Kundahl E; Shepherd GW
    Cell Biol Int Rep; 1980 Feb; 4(2):129-35. PubMed ID: 7388965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation characteristics of human neuroblastoma cells in the presence of growth modulators and antimitotic drugs.
    Gupta M; Notter MF; Felten S; Gash DM
    Brain Res; 1985 Mar; 351(1):21-9. PubMed ID: 2986788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of mitomycin C, hydroxylamine & bromodeoxyuridine on cell cycle kinetics & sister chromatid exchange frequency of muntjac lymphocytes.
    Gupta P; Sharma T
    Indian J Exp Biol; 1982 Oct; 20(10):726-30. PubMed ID: 6819223
    [No Abstract]   [Full Text] [Related]  

  • 25. [Matrix and physicochemical properties of DNA isolated from cells cultivated on a medium with 5-bromodeoxyuridine].
    Barskaia TV; Grishchenko IuD; Zakharova NV; Pogodina ON; Fridlianskaia II
    Tsitologiia; 1974; 16(6):747-51. PubMed ID: 4837596
    [No Abstract]   [Full Text] [Related]  

  • 26. Bromodeoxyuridine induced variations in the level of alkaline phosphatase in several human heteroploid cell lines.
    Bulmer D; Stocco D; Morrow J
    J Cell Physiol; 1976 Mar; 87(3):357-65. PubMed ID: 1254656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aluminium and Alzheimer's disease: sites of aluminium-binding in human neuroblastoma cells.
    Dobson CB; Templar J; Day JP; Itzhaki RF
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):321S. PubMed ID: 8224466
    [No Abstract]   [Full Text] [Related]  

  • 28. Increased level of prolactin gene sequences in bromodeoxyuridine treated GH cells.
    Biswas DK; Hanes SD
    Nucleic Acids Res; 1982 Jul; 10(13):3995-4008. PubMed ID: 7111026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Flow cytometric measurements of in vivo incorporated bromodeoxy- uridine into the DNA of experimental and human tumors].
    Kärcher H; McNally NJ; Wilson G; Kärcher KH; Pfragner R
    Wien Klin Wochenschr; 1985 Nov; 97(22):850-5. PubMed ID: 4082602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of various inhibitors on the expression of polyoma virus-induced surface antigen in BHK21 cells.
    Birg F; Meyer G
    J Gen Virol; 1973 Jul; 20(1):89-95. PubMed ID: 4356684
    [No Abstract]   [Full Text] [Related]  

  • 31. Co-cultivation of tumorigenic mouse melanoma cells with cells of a non-tumorigenic subclone inhibits plasminogen activator expression by the melanoma cells.
    Kyner D; Christman J; Acs G; Silagi S; Newcomb EW; Silverstein SC
    J Cell Physiol; 1978 May; 95(2):159-67. PubMed ID: 206566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Synergism of bromodeoxyuridine and mitomycin C in the production of chromosomal aberrations in Fanconi's anemia].
    Frías S; Molina B; Carnevale A
    Rev Invest Clin; 1989; 41(1):31-5. PubMed ID: 2499026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of SV40 T antigen in transformed hamster cells by chronic treatment with 5-bromo-2-deoxyuridine.
    Kreider JW; Del Villano B; Shoff WH; Davidson EA
    Cancer Res; 1972 Oct; 32(10):2148-55. PubMed ID: 4343009
    [No Abstract]   [Full Text] [Related]  

  • 34. A familial variant of chromosome 9.
    Palmer CG; Schroder J
    J Med Genet; 1971 Jun; 8(2):202-8. PubMed ID: 5096543
    [No Abstract]   [Full Text] [Related]  

  • 35. The production of acidic polysaccharides by 5-bromodeoxyuridine-treated B16 mouse melanoma cells.
    Sato C; Kreider JW; Banks J; Garlick S; Davidson EA
    Cancer Res; 1975 Sep; 35(9):2532-9. PubMed ID: 1170945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of nerve growth factor on neuroblast cultures from C 1300 neuroblastoma].
    Hermetet JC; Ciesielski-Treska J; Mandel P
    C R Seances Soc Biol Fil; 1972; 166(8):1120-3. PubMed ID: 4660180
    [No Abstract]   [Full Text] [Related]  

  • 37. [Bromodeoxyuridine-induced weakening of DNA--protein interaction in chromatin according to nucleoprotein--celite chromatography].
    Zaboĭkin MM; Kolobkov SL; S'iakste NI; Likhtenshteín AV; Shapot VS
    Biull Eksp Biol Med; 1980 Apr; 89(4):420-2. PubMed ID: 7388157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the mechanism of 5-bromodeoxyuridine induction of prolactin synthesis in rat pituitary tumor cells.
    Biswas DK; Abdullah KT; Brennessel BA
    J Cell Biol; 1979 Apr; 81(1):1-9. PubMed ID: 479283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of bromodeoxyuridine on radiation-induced DNA damage and repair based on DNA fragment size using pulsed-field gel electrophoresis.
    Lawrence TS; Davis MA; Normolle DP
    Radiat Res; 1995 Dec; 144(3):282-7. PubMed ID: 7494871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation.
    Raschella G; Romeo A; Negroni A; Pucci S; Dominici C; Castello MA; Bevilacqua P; Felsani A; Calabretta B
    Cancer Res; 1994 Apr; 54(8):2251-5. PubMed ID: 8174135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.